Showing results (101-110 of 125) with videos related to
Sort By:
Pageof 13
JAMA|May 22, 2014
Effectiveness of paliperidone palmitate vs haloperidol decanoate for maintenance treatment of schizophrenia: a randomized clinical trialJoseph P McEvoy, Matthew Byerly, Robert M Hamer, et al.Plos One|July 7, 2012
Plasma BDNF levels vary in relation to body weight in femalesAnilkumar Pillai, Davide Bruno, Antero S Sarreal, et al.The Journal of Clinical Psychiatry|June 6, 2009
Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior responseJean-Pierre Lindenmayer, Hong Liu-Seifert, Pandurang M Kulkarni, et al.Journal of Psychiatric Research|April 16, 2022
25-Hydroxyvitamin D and metabolic-related laboratory values in women with schizophrenia and hyperprolactinemiaMadhulika C Nallani, Megan M Powell, Sharon Pugh, et al.Psychiatric Services (Washington, D.C.)|August 2, 2016
Comparison of Injectable and Oral Antipsychotics in Relapse Rates in a Pragmatic 30-Month Schizophrenia Relapse Prevention StudyPeter F Buckley, Nina R Schooler, Donald C Goff, et al.Medrxiv : the Preprint Server for Health Sciences|November 24, 2025
Latent class analysis of symptoms across schizophrenia, schizoaffective disorder, and bipolar I disorderDana M Lapato, Roseann E Peterson, Eric D Achtyes, et al.Schizophrenia Research|July 18, 2020
Distinguishing patterns of impairment on inhibitory control and general cognitive ability among bipolar with and without psychosis, schizophrenia, and schizoaffective disorderMilena Y Gotra, Scot K Hill, Elliot S Gershon, et al.Schizophrenia Research|October 24, 2017
Genetic analysis of deep phenotyping projects in common disordersElliot S Gershon, Godfrey Pearlson, Matcheri S Keshavan, et al.Schizophrenia Bulletin|May 30, 2014
Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE studyPeter F Buckley, Nina R Schooler, Donald C Goff, et al.Journal of Clinical Psychopharmacology|July 16, 2008
Standard and higher dose of olanzapine in patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, fixed-dose studyBruce J Kinon, Jan Volavka, Virginia Stauffer, et al.Pageof 13